Breaking Stories

Capitol Report: Biden’s move on vaccine patents represents blow for the second-biggest spender on Washington lobbying

0

The Biden administration’s Wednesday decision to support waiving intellectual-property protections for COVID-19 vaccines counts as a significant disappointment for drugmakers, who rank among the biggest spenders on Washington lobbying.

Market Extra: Federal stimulus is a ‘lifeline’ for communities whacked by the corona-crisis, as scars of 2008 linger

Previous article

Metals Stocks: Gold prices top $1,800, settle at highest since February

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *